Rigel Pharmaceuticals (RIGL) Cash & Equivalents Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Rigel Pharmaceuticals | 551.62 Mn | 404.94 Mn | 54.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.02% |
| Dec 31, 2025 | 5.97% |
| Sep 30, 2025 | 5.83% |
| Jun 30, 2025 | 7.93% |
| Mar 31, 2025 | 0.22% |
| Dec 31, 2024 | 20.30% |
| Sep 30, 2024 | 5.75% |
| Jun 30, 2024 | -4.01% |
| Mar 31, 2024 | -19.30% |
| Dec 31, 2023 | -15.55% |
| Sep 30, 2023 | -5.88% |
| Jun 30, 2023 | -5.59% |
| Mar 31, 2023 | 0.08% |
| Dec 31, 2022 | -8.57% |
| Sep 30, 2022 | 2.91% |
| Jun 30, 2022 | -3.55% |
| Mar 31, 2022 | -9.27% |
| Dec 31, 2021 | 1.39% |
| Sep 30, 2021 | 3.22% |
| Jun 30, 2021 | 27.73% |
| Mar 31, 2021 | 7.04% |
| Dec 31, 2020 | -6.91% |
| Sep 30, 2020 | -1.06% |
| Jun 30, 2020 | 16.10% |
| Mar 31, 2020 | 1.15% |
| Dec 31, 2019 | 8.18% |
| Sep 30, 2019 | 24.99% |
| Jun 30, 2019 | 13.12% |
| Mar 31, 2019 | 38.03% |
| Dec 31, 2018 | 29.63% |
| Sep 30, 2018 | 30.85% |
| Jun 30, 2018 | 24.37% |
| Mar 31, 2018 | 3.27% |
| Dec 31, 2017 | 2.72% |
| Sep 30, 2017 | -0.70% |
| Jun 30, 2017 | 4.50% |
| Mar 31, 2017 | 12.75% |
| Dec 31, 2016 | -1.10% |
| Sep 30, 2016 | 6.79% |
| Jun 30, 2016 | -10.30% |
| Mar 31, 2016 | -11.11% |
| Dec 31, 2015 | 37.39% |
| Sep 30, 2015 | 11.83% |
| Jun 30, 2015 | -11.71% |